Key result
Cardiovascular disease and hypertensive disorders account for about one-quarter to one-third of maternal and peripartum deaths, highlighting the need for better risk stratification in pregnancy.
Why the study?
Existing risk-stratification scores predominantly focus on known preexisting heart disease, presenting a challenge in identifying patients at risk for pregnancy-related cardiovascular complications including cardiogenic shock.
Cardiovascular disease is a leading cause of maternal mortality, and identifying pregnant patients at risk for complications like cardiogenic shock remains a significant challenge despite existing risk-stratification tools.
Answers are grounded in this paper and cite their sources.
Supports prioritizing cardiovascular assessment in pregnancy; leaves open validation of improved risk-stratification tools.
Maternal mortality rates are rising in the United States, a trend which is in contrast to that seen in other high-income nations. Cardiovascular disease and hypertensive disorders of pregnancy are consistently the leading causes of maternal mortality both in the United States and globally, accounting for about one-quarter to one-third of maternal and peripartum deaths. A large proportion of cardiovascular morbidity and mortality stems from acquired disease in the context of cardiovascular risk factors, which include obesity, pre-existing diabetes and hypertension, and inequities in care from maternal care deserts and structural racism. Patients may also become pregnant with preexisting structural heart disease, or acquire disease throughout pregnancy (ex: spontaneous coronary artery dissection, peripartum cardiomyopathy), and be at higher risk of pregnancy-related cardiovascular complications. While risk-stratification tools including the modified World Health Organization (mWHO) classification, Cardiac Disease in Pregnancy (CARPREG II) and Zwangerschap bij Aangeboren HARtAfwijking/Pregnancy in Women with Congenital Heart Disease (ZAHARA) have been designed to help physicians identify patients at increased risk for adverse pregnancy outcomes and who may therefore benefit from referral to a tertiary care center, the limitation of these scores is their predominant focus on patients with known preexisting heart disease. As such, identifying patients at risk for pregnancy complications presents a significant challenge, and it is often patients with high-risk cardiovascular substrates prior to or during pregnancy who are at a highest risk for adverse pregnancy outcomes including cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
O’Kelly et al. (2024) conducted a review in Cardiovascular complications and cardiogenic shock in pregnancy. Cardiovascular disease and hypertensive disorders account for about one-quarter to one-third of maternal and peripartum deaths, highlighting the need for better risk stratification in pregnancy.
Synapse has enriched 10 related papers. Consider them for comparative context: